Trials / Withdrawn
WithdrawnNCT01217580
Pain Relief Study of Ultrasound Guided Transverse Abdominis Plane(TAP)Block
Analgesic Efficacy of Ultrasound Guided Transversus Abdominis Plane Block After Cesarean Delivery in Patients With a BMI > 30
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Ochsner Health System · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if injecting a local anesthetic, or numbing medication, above each hip will decrease the amount of narcotic pain medicine that is typically required by a patient after a cesarean delivery. Ultrasound pictures will be used to guide placement of this injection. Either ropivicaine (a type of numbing medication called a local anesthetic) or a placebo (saline) will be injected. For 24 hours, you will be given a button to press when you have pain. When the button is pressed, you will be given a small amount of pain medication called hydromorphone through your IV. You will also be given a pain medication called ketorolac through your IV every 8 hours for 24 hours after surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0.5% ropivacaine | 20ml each side of the hip of 0.5% ropivacaine into the transverse abdominis plane after patient is brought to the recovery area after elective cesarean delivery |
| DRUG | 0.9% sodium chloride | 20ml each side of the hip of 0.9% sodium chloride into the transverse abdominis plane after patient is brought to the recovery area after elective cesarean delivery |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2011-10-01
- Completion
- 2011-10-01
- First posted
- 2010-10-08
- Last updated
- 2023-04-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01217580. Inclusion in this directory is not an endorsement.